DP

Dheera Parth Thakkar

Active Director Designated Partner DIN 10574790
DIN 10574790 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dheera Parth Thakkar

Data last updated:

Dheera Parth Thakkar is a Designated Partner at Zelcon Lifesciences Llp (since 2024). The company operates in Pharma.

DIN 10574790
Primary Designation Designated Partner
Industry Pharma
First Appointment 02 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Apr 20242024Active

Board colleagues of Dheera Parth Thakkar

NameDINCompanyDesignation
Najuk Dhaivat Vasavada10574791Zelcon Lifesciences LlpDesignated Partner
Preeti Prakash Thakkar10574789Zelcon Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Zelcon Lifesciences Llp
Premium access

Shareholding and investment profile for Dheera Parth Thakkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dheera Parth Thakkar

Dheera Parth Thakkar currently holds 1 directorship: Zelcon Lifesciences Llp (Designated Partner, since 02 Apr 2024).

Dheera Parth Thakkar was first appointed on 02 Apr 2024 as Designated Partner at Zelcon Lifesciences Llp.

The current boards of Dheera Parth Thakkar's companies include Najuk Dhaivat Vasavada (Zelcon Lifesciences Llp), Preeti Prakash Thakkar (Zelcon Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available